Michael Hofman: Unite to Fight Cancer with the PSMA Pioneers!
Michael Hofman, Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProSTIC) at Peter MacCallum Cancer Centre, posted on X:
“Unite to Fight Cancer with the PSMA Pioneers! Join Us in the Fight Against Cancer: Celebrating 10 Years of Breakthroughs for Men with Prostate Cancer.
Make a donation today to support Unite to Fight Cancer.
In 2015, we made history by performing Australia’s first-ever Lutetium-PSMA treatment as part of a groundbreaking clinical trial. This pioneering therapy has since transformed prostate cancer care worldwide, offering men with aggressive prostate cancer a new targeted treatment that improves both longevity and quality of life.
For a decade, we’ve been at the forefront of innovation – leading over 10 clinical trials and bridging cutting-edge science with clinical care to uncover the next generation of life-changing cancer treatments.
Your support fuels this vital work. Together, we can continue to rewrite the future for men battling prostate cancer. Sign up today and be part of the movement that saves lives.”
More posts featuring Michael Hofman.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023